Epigenetic changes are implicated in a host of neural conditions, from Alzheimer's-related memory loss to depression. Now, a revolutionary set of molecular editing tools are allowing scientists to alter the epigenome like never before. In The Mix, UAB neuroscientist Jeremy Day, Ph.D., explains how he uses these techniques in his lab, and why they could lead to an entirely new kind of therapy.
New International Journal of Obesity paper offers an algorithm to more accurately predict body weight change outcomes.
The manufacturer of a new medication for Rett syndrome studied at UAB is encouraged by the drug’s performance.